Simplifying Global Compliance
Survey Shows Companies Aim to Increase Range of Patient Data in Clinical Trials
Clinical Trials Advisor
Most life sciences companies plan to significantly step up their use of real-world data sources over the next three years, according to a new survey by the Tufts Center for the Study of Drug Development.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing